Cargando…
Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development – A Systematic Review
Translation from preclinical animal research to clinical bedside has proven to be difficult to impossible in many fields of research (e.g. acute stroke, ALS and HIV vaccination development) with oncology showing particularly low translation rates (5% vs. 20% for cardiovascular diseases). Several inv...
Autores principales: | Martić-Kehl, Marianne Isabelle, Wernery, Jannis, Folkers, Gerd, Schubiger, Pius August |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589433/ https://www.ncbi.nlm.nih.gov/pubmed/26421849 http://dx.doi.org/10.1371/journal.pone.0137235 |
Ejemplares similares
-
Impact of inherent variability and experimental parameters on the reliability of small animal PET data
por: Martic-Kehl, Marianne Isabelle, et al.
Publicado: (2012) -
Can animal data predict human outcome? Problems and pitfalls of translational animal research
por: Martić-Kehl, Marianne I., et al.
Publicado: (2012) -
Help-Seeking in People with Exceptional Experiences: Results from a General Population Sample
por: Landolt, Karin, et al.
Publicado: (2014) -
Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017) -
Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)